MARKET

INVA

INVA

Innoviva
NASDAQ

Real-time Quotes | Nasdaq Last Sale

15.10
-0.13
-0.82%
After Hours: 15.10 0 0.00% 17:28 02/20 EST
OPEN
15.20
PREV CLOSE
15.23
HIGH
15.35
LOW
14.99
VOLUME
1.24M
TURNOVER
--
52 WEEK HIGH
16.29
52 WEEK LOW
10.03
MARKET CAP
1.53B
P/E (TTM)
10.89
1D
5D
1M
3M
1Y
5Y

Buy or sell shares of INVA and other stocks commission-free!

Open a Webull account and fund it to get a free stock

Analyst Rating

Based on 2 analysts

Hold

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

EPS

INVA News

  • Healthcare And Biotechnology Dashboard - Update
  • Seeking Alpha - Article.2d ago
  • Taking Profits In Innoviva
  • Seeking Alpha - Article.02/12 15:06
  • A Closer Look At Innoviva, Inc.'s (NASDAQ:INVA) Impressive ROE
  • Simply Wall St..02/12 13:02
  • Innoviva EPS beats by $0.03, beats on revenue
  • seekingalpha.02/06 02:19

More

Industry

Pharmaceuticals
-0.54%
Pharmaceuticals & Medical Research
-0.40%

Hot Stocks

Name
Price
%Change

About INVA

Innoviva, Inc., formerly Theravance, Inc., is engaged in the development, commercialization and financial management of bio-pharmaceuticals. It focuses on the respiratory assets partnered with Glaxo Group Limited (GSK), including RELVAR/BREO ELLIPTA (fluticasone furoate (FF)/vilanterol (VI)) and ANORO ELLIPTA (umeclidinium bromide/vilanterol (UMEC/VI)). Under the Long-Acting Beta2 Agonist (LABA) Collaboration Agreement and the Strategic Alliance Agreement with GSK, the Company is eligible to receive the annual royalties from GSK on sales of RELVAR/BREO ELLIPTA. For other products combined with a LABA from the LABA collaboration, such as ANORO ELLIPTA, royalties are upward tiering and range from 6.5% to 10%. RELVAR/BREO is a once-a-day combination inhaled respiratory medicine consisting of a LABA (VI) and an inhaled corticosteroid (ICS), FF. ANORO ELLIPTA a once-daily medicine combining a long-acting muscarinic antagonist (LAMA), umeclidinium bromide (UMEC), with a LABA.
More

Webull offers Innoviva Inc (INVA) stock price, real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, stock news, and many more online research tools to help you make informed decisions.